MML Investors Services’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,920
Closed -$232K – 3303
2026
Q1
$232K Buy
3,920
+267
+7% +$17.3K ﹤0.01% 2735
2025
Q4
$225K Sell
3,653
-783
-18% -$47.9K ﹤0.01% 2813
2025
Q3
$277K Sell
4,436
-6,370
-59% -$443K ﹤0.01% 2585
2025
Q2
$863K Buy
10,806
+3,147
+41% +$263K ﹤0.01% 1746
2025
Q1
$658K Buy
7,659
+1,521
+25% +$125K ﹤0.01% 1831
2024
Q4
$479K Buy
6,138
+1,810
+42% +$141K ﹤0.01% 1943
2024
Q3
$312K Buy
4,328
+612
+16% +$43.3K ﹤0.01% 2159
2024
Q2
$256K Buy
3,716
+365
+11% +$24.7K ﹤0.01% 2193
2024
Q1
$243K Buy
3,351
+68
+2% +$4.55K ﹤0.01% 2246
2023
Q4
$201K Buy
+3,283
New +$195K ﹤0.01% 2318
2019
Q1
– Sell
-7,107
Closed -$219K – 1623
2018
Q4
$219K Sell
7,107
-43
-0.6% -$1.57K ﹤0.01% 1327
2018
Q3
$271K Buy
+7,150
New +$270K ﹤0.01% 1320

Other funds holding PBH

MML Investors Services's PBH Position: Q2 2026 in Review

MML Investors Services sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 3,920 shares — an estimated $232K sold.

MML Investors Services first reported a position in PBH in Q3 2018 and held it in 12 quarters. The position peaked at $863K in Q2 2025. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • MML Investors Services reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • MML Investors Services sold 3,920 Prestige Consumer Healthcare shares in Q2 2026, an estimated $232K.
  • MML Investors Services first reported a position in Prestige Consumer Healthcare in Q3 2018 and held it in 12 quarters.
  • MML Investors Services's Prestige Consumer Healthcare position peaked at $863K in Q2 2025.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.